SCHEMBL5590451

SCHEMBL5590451

CCCCCCCCCCc1ccc(O)c(O)c1CCCCCCCCCC

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 3/20 0.69
▸ ALOX5 P09917 5/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ TP53 P04637 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ BID P55957 3/20 0.45
▸ MCL1 Q07820 3/20 0.45
▸ BCL2L1 Q07817 2/20 0.45
▸ BAK1 Q16611 2/20 0.45
▸ KAT8 Q9H7Z6 2/20 0.45
▸ PPARG P37231 1/20 0.45
▸ PPARA Q07869 1/20 0.45
▸ EP300 Q09472 1/20 0.45
▸ KAT2A Q92830 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8936633 1.00 TYR (0.69) TYRALOX5MEN1TP53CYP3A4
SCHEMBL31052363 1.00 TYR (0.69) TYRALOX5MEN1TP53CYP3A4
SCHEMBL5589521 1.00 TYR (0.69) TYRALOX5MEN1TP53CYP3A4
SCHEMBL11698491 1.00 TYR (0.69) TYRALOX5MEN1TP53CYP3A4
SCHEMBL5586626 1.00 TYR (0.69) TYRALOX5MEN1TP53CYP3A4
SCHEMBL5588738 1.00 TYR (0.69) TYRALOX5MEN1TP53CYP3A4
SCHEMBL1208346 1.00 TYR (0.69) TYRALOX5MEN1TP53CYP3A4
SCHEMBL9772652 1.00 TYR (0.69) TYRALOX5MEN1TP53CYP3A4
SCHEMBL5588171 0.98 TYR (0.66) TYRALOX5MEN1TP53CYP3A4
SCHEMBL5195268 0.96 TYR (0.64) TYRALOX5MEN1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 — — US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 — — EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 — — US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 — — EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 TYR 1073/4885ALOX5 188/4885MEN1 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback